Skip to main content
Casey Bowen, MD, Dermatology, Lincoln, NE

CaseyDanielBowenMD

Dermatology Lincoln, NE

Board Certified Dermatologist

Dr. Bowen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Bowen's full profile

Already have an account?

  • Office

    6969 South St
    Lincoln, NE 68506
    Phone+1 402-413-7460
    Fax+1 402-413-7486

Summary

  • Dr. Casey Bowen is a board certified dermatologist in Lincoln, NE. He received his medical degree from University of Nebraska College of Medicine and has been in practice 11 years. He is experienced in medical dermatology, skin cancer screening and treatment. He is experienced in pediatric dermatology and the diagnosis and management of atopic dermatitis (eczema), allergic contact dermatitis, and other inflammatory skin conditions. His work in the medical literature is widely read and referenced.

Education & Training

  • San Antonio Uniformed Services Health Education Consortium
    San Antonio Uniformed Services Health Education ConsortiumResidency, Dermatology, 2012 - 2015
  • Louisiana State University School of Medicine
    Louisiana State University School of MedicineResidency, Internal Medicine, 2008 - 2009
  • University of Nebraska College of Medicine
    University of Nebraska College of MedicineClass of 2008

Certifications & Licensure

  • NE State Medical License
    NE State Medical License 2017 - 2026
  • KS State Medical License
    KS State Medical License 2024 - 2025
  • TX State Medical License
    TX State Medical License 2015 - 2021
  • LA State Medical License
    LA State Medical License 2009 - 2015
  • American Board of Dermatology Dermatology

Publications & Presentations

PubMed

Research History

  • Compassiopnate use of Gr-md-02 for atopic dermatitisStudy looked at the use of an investigational new drug in the management of refractory moderate to severe atopic dermatitis (eczema).2015 - 2017

Professional Memberships